MicroRNA-143 is Associated With Pathological Complete Response and Regulates Multiple Signaling Proteins in Breast Cancer

Almost 55% to 80% of patients with breast cancer have an unfavorable pathological complete response to chemotherapy. MicroRNAs are small noncoding RNAs involved in cancer progression; however, their utility as predictors of pathological complete response to neoadjuvant chemotherapy is unclear. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Vázquez, Raúl, Marchat, Laurence A., Ruíz-García, Erika, Astudillo-de la Vega, Horacio, Meneses-García, Abelardo, Arce-Salinas, Claudia, Bargallo-Rocha, Enrique, Carlos-Reyes, Ángeles, López-González, José Sullivan, Pérez-Plasencia, Carlos, Ramos-Payán, Rosalío, Aguilar-Medina, Maribel, López-Camarillo, César
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378643/
https://www.ncbi.nlm.nih.gov/pubmed/30755102
http://dx.doi.org/10.1177/1533033819827309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378643/
https://www.ncbi.nlm.nih.gov/pubmed/30755102
http://dx.doi.org/10.1177/1533033819827309

Ejemplares similares